CytoTronics

About

CytoTronics is a biotechnology company based in Boston, Massachusetts, founded in 2019 and established as a spin-off from Harvard University in 2021. The company specializes in the integration of cell biology and technology, focusing on high-throughput, semiconductor-based platforms for live cell function analysis. This work is essential for cell biology discovery, drug development, and pharmaceutical manufacturing. The flagship product, the Pixel system, combines semiconductors with conventional microplates to deliver multi-modal capabilities, including electrical, electrochemical, and electrophysiological analysis. This system provides real-time insights at single-cell resolution, supporting applications such as cell viability monitoring, electrophysiology, metabolism analysis, and high-throughput screening. CytoTronics serves a diverse customer base, including biopharmaceutical companies, academic researchers, cell model providers, and contract research organizations. The leadership team includes co-founders Jeffrey Abbott, PhD, and Vince Wu, PhD, who bring expertise in engineering, bioelectronics, and AI/ML applications in biology.